The U.S. Patent and Trademark Office will be holding its next biotechnology/chemical/pharmaceutical (BCP) customer partnership meeting on January 28, 2020 at the USPTO Headquarters in Alexandria, VA.  The agenda for the meeting is as follows:

• Welcoming and Opening Remarks (10:30 – 10:40 am ET) — Gary Jones and Andrew Wang, Directors, and Karl Skowronek, Director (Acting), TC1600, USPTO

• Restriction practice (10:40 – 11:20 am) — Janet Andres, SPE, TC1600, USPTO

• Orange Book and biologic patent study 11:20 – 12:00 pm) — Michelle Ankenbrand, Lead Administrative Patent Judge, and Jason Repko, Administrative Patent Judge, PTAB, USPTO

• Lunch/Networking (12:00 – 1:00 pm)

• Patent term adjustment (1:00 – 1:50 pm) — Kery Fries, Senior Legal Advisor, OPLA, USPTO

• Satisfying the written description requirement for living inventions (1:50 – 2:50 pm) — Bethany Reid Roahrig, Patent Agent, Setter Roche LLP

• Break (2:50 – 3:00 pm)

• Subject matter eligibility (101) update (3:00 – 4:30 pm) – Zachariah Lucas, QAS, TC1600, USPTO

• Closing Remarks (4:30 – 4:40 pm) – Directors, TC1600, USPTO

Additional information regarding the BCP customer partnership meeting, including registration information for those wishing to attend the meeting or register for online participation, can be found here.